ARCADIUM LITHIUM CDI/1
Rio Tinto Lithium produces lithium chemicals products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers battery-grade lithium hydroxide, lithium carbonate, butyllithium and high purity lithium metal for electric vehicles, primary battery, greases and industrial, pharmaceutical, polymers, and aerospace applications. It also owns interest in … Read more
ARCADIUM LITHIUM CDI/1 (7WO) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ARCADIUM LITHIUM CDI/1 (7WO) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ARCADIUM LITHIUM CDI/1 - Net Assets Trend (None–None)
This chart illustrates how ARCADIUM LITHIUM CDI/1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ARCADIUM LITHIUM CDI/1 (None–None)
The table below shows the annual net assets of ARCADIUM LITHIUM CDI/1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ARCADIUM LITHIUM CDI/1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ARCADIUM LITHIUM CDI/1 Competitors by Market Cap
The table below lists competitors of ARCADIUM LITHIUM CDI/1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ONO PHARMACEUT.
F:ON4
|
$5.96 Billion |
|
Chewy Inc
NYSE:CHWY
|
$5.96 Billion |
|
GD Power Development Co Ltd
SHG:600795
|
$5.96 Billion |
|
Chord Energy Corp
NASDAQ:CHRD
|
$5.96 Billion |
|
Tongwei Co Ltd
SHG:600438
|
$5.96 Billion |
|
Matador Resources Company
NYSE:MTDR
|
$5.95 Billion |
|
Hyatt Hotels Corporation
NYSE:H
|
$5.95 Billion |
|
Zhejiang Supcon Technology Co. Ltd. A
SHG:688777
|
$5.95 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ARCADIUM LITHIUM CDI/1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ARCADIUM LITHIUM CDI/1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ARCADIUM LITHIUM CDI/1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ARCADIUM LITHIUM CDI/1's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ARCADIUM LITHIUM CDI/1 (7WO) | €- | N/A | N/A | $5.96 Billion |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |